Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Vascular Endothelial Growth Factor Receptor 2 Mediates Macrophage Infiltration into Orthotopic Pancreatic Tumors in Mice
2008
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**
2021 StandoutNobel
Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo
2018 Standout
Techniques for extraction and isolation of natural products: a comprehensive review
2018 Standout
Smarter drugs emerging in pancreatic cancer therapy
2014
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
2008
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Tubulin-Targeted Agents Including Docetaxel and Cabazitaxel
2013
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
2011
Review of the Apoptosis Pathways in Pancreatic Cancer and the Anti‐apoptotic Effects of the Novel Sea Cucumber Compound, Frondoside A
2008
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Reactive oxygen species in cancer
2010 Standout
Oxygen sensing in the body
2005 StandoutNobel
Integration of EGFR inhibitors with radiochemotherapy
2006
Sphingosine Kinase Type 1 Promotes Estrogen-Dependent Tumorigenesis of Breast Cancer MCF-7 Cells
2002
Emerging drugs for non-small-cell lung cancer
2007
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors
2008
Sphingosine-1-phosphate: an enigmatic signalling lipid
2003 Standout
ROS signalling in the biology of cancer
2017 Standout
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Natural polyphenols: An overview
2016 Standout
Bonding and structure trends of thiosemicarbazone derivatives of metals—An overview
2008 Standout
Cation control on the synthesis of p-t-butylthiacalix[4](bis)crown ethers
2002
Stimulus interaction in the responses of carotid body chemoreceptor single afferent fibers
1975
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Scaffold Diversity through Intramolecular Cascade Reactions of Solid-Supported Cyclic N-Acyliminium Intermediates
2007 StandoutNobel
Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer
2008
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Marine natural products
2015 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung Cancer
2006
A Computational Model for Overcoming Drug Resistance Using Selective Dual-Inhibitors for Aurora Kinase A and Its T217D Variant
2013 StandoutNobel
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer
2013
Antibody−Dendrimer Conjugates: The Number, Not the Size of the Dendrimers, Determines the Immunoreactivity
2008
Comprehensive Survey of Combinatorial Library Synthesis: 2005
2006
Methodische Untersuchungen zur polarographischen Messung der Atmung und des ?kritischen Sauerstoffdrucks? bei Mitochondrien und isolierten Zellen mit der membranbedeckten Platinelektrode
1972
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
2009
Mice with a human touch
2007
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Diphenyllead(IV) Chloride Complexes with Benzilthiosemicarbazones. The First Bis(Thiosemicarbazone) Derivatives
2007
Multiple Myeloma
2011 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Crown Ethers: Sensors for Ions and Molecular Scaffolds for Materials and Biological Models
2004 Standout
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure−Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
2010
Recent Advances in the Chemical Synthesis of C-Glycosides
2017
Works of Dirk Weber being referenced
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
2012
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer
2006
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a
2011
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
2006
Phosphorylation of p-tert-butylthiacalix[4]arene: reaction with phosphorous triamides
2000
A phase I study of a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody “EMD72000 (Matuzumab)” administered weekly in Japanese patients with advanced solid tumors; safety, PK and PD results of skin biopsies
2005
Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
2000
Unexpected differences in reactivity between tin and lead organyl chlorides – crystal structures of their organylphosphonium salts
2003
Increased risk of thrombosis with lenalidomide in combination with dexamethasone and erythropoietin
2006
Design of Selective Peptidomimetic Agonists for the Human Orphan Receptor BRS-3
2003
Measurements of the criticalPO2 of renal mitochondria
1971
Efficient Synthesis of Empagliflozin, an Inhibitor of SGLT-2, Utilizing an AlCl3-Promoted Silane Reduction of a β-Glycopyranoside
2014
Randomized phase II trial of patupilone plus prednisone versus docetaxel plus prednisone in patients with chemotherapy-naïve, metastatic, castrate-resistant prostate cancer (CRPC).
2010